価格表

在庫・価格 : 2025年05月07日 08時47分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-RBM3, Mouse-Mono(CL0296)
データシート
AMAb90655 AABアトラスアンチボディーズ
Atlas Antibodies AB
100 μl ¥119,000
(未発注)
追加

在庫・価格 : 2025年05月07日 08時47分 現在

Anti-RBM3, Mouse-Mono(CL0296)

  • 商品コード:AMAb90655
  • メーカー:AAB
  • 包装:100μl
  • 価格: ¥119,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ehl辿n A et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med 2010;8:78
Ehl辿n A et al
2010/01/01
PubMed
2 Ehlén Å et al. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Transl Oncol 2011 Aug;4(4):212-21
Ehlén Å et al
2011/01/01
PubMed
3 Hjelm B et al. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. Proteomics Clin Appl 2011 Dec;5(11-12):624-35
Hjelm B et al
2011/01/01
PubMed
4 Jonsson L et al. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. J Transl Med 2011;9:114
Jonsson L et al
2011/01/01
PubMed
5 Jonsson L et al. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. Diagn Pathol 2011;6:91
Jonsson L et al
2011/01/01
PubMed
6 Nodin B et al. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Diagn Pathol 2012;7:82
Nodin B et al
2012/01/01
PubMed
7 Boman K et al. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer. BMC Urol 2013;13:17
Boman K et al
2013/01/01
PubMed
8 Dubois L et al. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. BMC Res Notes 2013;6:542
Dubois L et al
2013/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ehl辿n A et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med 2010;8:78
    Ehl辿n A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Ehlén Å et al. RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Transl Oncol 2011 Aug;4(4):212-21
    Ehlén Å et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hjelm B et al. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. Proteomics Clin Appl 2011 Dec;5(11-12):624-35
    Hjelm B et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Jonsson L et al. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. J Transl Med 2011;9:114
    Jonsson L et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Jonsson L et al. High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression. Diagn Pathol 2011;6:91
    Jonsson L et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Nodin B et al. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Diagn Pathol 2012;7:82
    Nodin B et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Boman K et al. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer. BMC Urol 2013;13:17
    Boman K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Dubois L et al. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. BMC Res Notes 2013;6:542
    Dubois L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed